BIODELIVERY SCIENCES INTL IN's ticker is BDSI and the CUSIP is 09060J106. A total of 154 filers reported holding BIODELIVERY SCIENCES INTL IN in Q3 2021. The put-call ratio across all filers is 0.81 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $1,772,000 | -20.1% | 572,083 | -6.9% | 0.00% | – |
| Q3 2021 | $2,219,000 | -17.7% | 614,750 | -18.4% | 0.00% | – |
| Q2 2021 | $2,696,000 | +212.4% | 753,186 | +241.4% | 0.00% | – |
| Q1 2021 | $863,000 | +19.7% | 220,645 | +28.7% | 0.00% | – |
| Q4 2020 | $721,000 | +472.2% | 171,494 | +412.7% | 0.00% | – |
| Q3 2020 | $126,000 | -3.1% | 33,452 | +11.9% | 0.00% | – |
| Q2 2020 | $130,000 | +25.0% | 29,904 | +9.1% | 0.00% | – |
| Q1 2020 | $104,000 | -39.9% | 27,408 | +0.1% | 0.00% | – |
| Q4 2019 | $173,000 | +50.4% | 27,383 | 0.0% | 0.00% | – |
| Q3 2019 | $115,000 | -91.9% | 27,383 | -91.5% | 0.00% | – |
| Q2 2019 | $1,414,000 | -63.3% | 321,200 | -55.8% | 0.00% | -100.0% |
| Q1 2019 | $3,851,000 | +142.0% | 726,578 | +69.0% | 0.00% | – |
| Q4 2018 | $1,591,000 | +112.1% | 429,913 | +60.5% | 0.00% | – |
| Q3 2018 | $750,000 | +28.9% | 267,874 | +35.8% | 0.00% | – |
| Q2 2018 | $582,000 | +268.4% | 197,241 | +267.5% | 0.00% | – |
| Q4 2017 | $158,000 | +36.2% | 53,667 | +36.0% | 0.00% | – |
| Q3 2017 | $116,000 | +2220.0% | 39,467 | +1612.2% | 0.00% | – |
| Q2 2016 | $5,000 | -99.5% | 2,305 | -99.2% | 0.00% | – |
| Q1 2016 | $961,000 | -28.1% | 297,533 | +6.6% | 0.00% | – |
| Q4 2015 | $1,336,000 | -24.5% | 279,000 | -12.3% | 0.00% | – |
| Q3 2015 | $1,770,000 | -11.2% | 318,294 | +27.0% | 0.00% | – |
| Q2 2015 | $1,994,000 | +115.3% | 250,592 | +184.4% | 0.00% | – |
| Q1 2015 | $926,000 | -10.3% | 88,127 | +2.7% | 0.00% | – |
| Q4 2014 | $1,032,000 | -34.2% | 85,850 | -6.5% | 0.00% | – |
| Q3 2014 | $1,569,000 | -11.9% | 91,800 | -37.7% | 0.00% | – |
| Q2 2014 | $1,780,000 | +20.6% | 147,425 | -15.7% | 0.00% | – |
| Q1 2014 | $1,476,000 | +71.2% | 174,850 | +19.5% | 0.00% | – |
| Q4 2013 | $862,000 | +5.9% | 146,375 | -2.4% | 0.00% | – |
| Q3 2013 | $814,000 | +53.6% | 149,993 | +14.8% | 0.00% | – |
| Q2 2013 | $530,000 | – | 130,639 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 1,575,000 | $6,615,000 | 4.38% |
| 1492 Capital Management LLC | 790,863 | $3,322,000 | 1.91% |
| Rubric Capital Management LP | 3,516,124 | $14,768,000 | 1.08% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 9,530,000 | $40,026,000 | 0.79% |
| Zebra Capital Management LLC | 144,241 | $606,000 | 0.77% |
| KNOTT DAVID M | 370,230 | $1,555,000 | 0.70% |
| Nantahala Capital Management | 5,123,671 | $21,519,000 | 0.67% |
| SYSTEMATIC FINANCIAL MANAGEMENT LP | 3,593,893 | $15,094,000 | 0.66% |
| EMC Capital Management | 98,933 | $416,000 | 0.32% |
| ALGERT GLOBAL LLC | 175,170 | $736,000 | 0.21% |